The use of IgM antibody detection for the classification of the primary and secondary
measles antibody response in persons following primary and secondary vaccination and …

Background The effect of age at first dose on the immunogenicity of a 2-dose pediatric
schedule of measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV) …

Children aged 9–11, 12–14 or 15–17 months, respectively were vaccinated with a measles,
mumps and rubella (MMR) vaccine and serum antibody responses and reactogenicity were …

During the 1997–1998 measles epidemic in Poland a high attack rate occurred in infants up
to 1 year of age (24.6/100,000 in comparison with 5.5/100,000 in total population). Routine …

Background. Given the high infant measles mortality rate, there is interest in whether a
measles immunization regimen beginning at< 12 months of age provides lasting immunity …

Background. Shifts in peak measles incidence to children< 12 months old and the
associated high mortality support the study of an early 2-dose measles vaccine regimen …

A nation‐wide measles outbreak occurred in 1988 in Taiwan. A retrospective cohort study
was conducted to define the protective titre of measles neutralising (NT) antibody. Paired …

Background Since 1989 the American Academy of Pediatrics and the ACIP have
recommended a second dose of measles-mumps-rubella vaccine (MMR®-II) at either school …

Vaccination at 6 months of age followed by routine revaccination is recommended when
exposure of infants to measles is likely. Dade County, Florida, began this early two-dose …

Serological evidence indicates that measles virus (MV) could circulate in seropositive, fully
protected populations. Among individuals fully protected against disease, those prone to …